je.st
news
Tag: biotech
CRL's bottom line continues to be driven by biotech growth, CEO says
2015-03-06 03:45:14| Biotech - Topix.net
For the second straight year Charles River Laboratories has seen more of its revenue derived from biotech companies than Big Pharma, CEO James Foster told investors at two conferences on Tuesday and Wednesday. The growth for CRL, which Foster called " an interesting phenomenon worth noting, " comes as biotech companies have become the drug discovery engines of Big Pharma.
Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
2015-03-05 00:53:04| Biotech - Topix.net
Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.
BIO Applauds COMPETE Act to encourage early biotech research.
2015-03-04 14:31:11| Industrial Newsroom - All News for Today
BIO applauded Senators Tom Carper and Pat Toomey for introducing COMPETE Act, which will spur biotech capital formation and stimulate innovative research and development. Specifically, BIO President and CEO Jim Greenwood voiced support concerning included provisions which make R&D tax credit permanent while increasing credit rate. Greenwood also commended increased credit in bill for innovative research expenses as well as encouragement of investment in early-stage, R&D-centric businesses.
Tags: research
early
act
encourage
Nutter Continues to Expand in Biotech and Pharma IP
2015-03-04 08:14:53| Biotech - Topix.net
Nutter McClennen & Fish LLP announced today that Lana A. Gladstein has joined the firm as a partner in Intellectual Property, adding her considerable life sciences expertise to the firm's highly regarded IP practice. Gladstein's practice focuses on strategic uses of intellectual property for biotechnology and pharmaceutical companies, including patent litigation, contested proceedings at the U.S. Patent Office, and product exclusivity guidance.
Tags: ip
expand
continues
biotech
Venture funding for biotech startups is seeing an uptick
2015-03-01 05:22:17| Biotech - Topix.net
Consider Grand Prairie-based Neos Therapeutics, which raised $20.6 million to support the regulatory review of a drug to treat attention deficit hyperactivity disorder. The investment, announced last week, was the latest funding for the specialized pharmaceutical company.
Tags: seeing
funding
venture
biotech
Sites : [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] next »